APA
Pavo N., Arfsten H., Cho A., Goliasch G., Bartko P. E., Wurm R., Freitag C., Gisslinger H., Kornek G., Strunk G., Raderer M., Zielinski C. & Hülsmann M. (20200918). The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients. : Scientific reports.
Chicago
Pavo Noemi, Arfsten Henrike, Cho Anna, Goliasch Georg, Bartko Philipp E, Wurm Raphael, Freitag Claudia, Gisslinger Heinz, Kornek Gabriela, Strunk Guido, Raderer Markus, Zielinski Christoph and Hülsmann Martin. 20200918. The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients. : Scientific reports.
Harvard
Pavo N., Arfsten H., Cho A., Goliasch G., Bartko P. E., Wurm R., Freitag C., Gisslinger H., Kornek G., Strunk G., Raderer M., Zielinski C. and Hülsmann M. (20200918). The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients. : Scientific reports.
MLA
Pavo Noemi, Arfsten Henrike, Cho Anna, Goliasch Georg, Bartko Philipp E, Wurm Raphael, Freitag Claudia, Gisslinger Heinz, Kornek Gabriela, Strunk Guido, Raderer Markus, Zielinski Christoph and Hülsmann Martin. The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients. : Scientific reports. 20200918.